The 2026 Medtech Impact Symposium examines how the industry can deliver high-quality treatment at a reasonable cost—for anyone and anywhere—while continuing to innovate and thrive.
Morning sessions will explore the challenges and opportunities of expanding access to care that is affordable, scalable, and sustainable. Discussions will address access, cost, and outcomes, alongside the policy and business models needed to advance care without constraining innovation.
In the afternoon, the Symposium shifts to three dynamic, concurrent tracks that examine the evolving landscape of healthcare delivery. Each track will feature practical, forward-looking dialogue focused on users, enabling technologies, and the accelerating shift in where care is delivered.
The day culminates in the Medtech Impact Gala, where the themes and insights from the Symposium are brought to life through the stories of patients and innovators. The Gala celebrates the real-world impact of medical technology, elevates the patient voice, and honors the individuals and organizations advancing healthcare for communities everywhere.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
